SB

Scott W. Bagley

Pfizer: 22 patents #123 of 5,153Top 3%
Merck: 7 patents #1,604 of 9,382Top 20%
Overall (All Time): #135,047 of 4,157,543Top 4%
28
Patents All Time

Issued Patents All Time

Showing 25 most recent of 28 patents

Patent #TitleCo-InventorsDate
12378230 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more 2025-08-05
12331041 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Edward L. Conn, John M. Curto, David James Edmonds, Mark E. Flanagan +7 more 2025-06-17
12319669 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2025-06-03
11858916 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, Edward L. Conn, John M. Curto, David James Edmonds, Mark E. Flanagan +7 more 2024-01-02
11802121 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2023-10-31
11661419 Benzimidazole derivative compounds and uses thereof Agustin Casimiro-Garcia, Xiayun Cheng, Jennifer Elizabeth Davoren, Rajiah Aldrin Denny, Brian Stephen Gerstenberger +4 more 2023-05-30
11512070 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2022-11-29
10934279 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more 2021-03-02
10851081 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2020-12-01
10683281 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more 2020-06-16
10676465 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more 2020-06-09
10669259 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2020-06-02
10208019 GLP-1 receptor agonists and uses thereof Gary Erik Aspnes, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more 2019-02-19
9181252 N1/N2-lactam acetyl-CoA carboxylase inhibitors David A. Griffith, Robert L. Dow, Aaron Smith 2015-11-10
9139587 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors David A. Griffith, Daniel Wei-Shung Kung 2015-09-22
8993586 N1/N2-lactam acetyl-CoA carboxylase inhibitors David A. Griffith, Robert L. Dow, Aaron Smith 2015-03-31
8859773 N1/N2-lactam acetyl-CoA carboxylase inhibitors David A. Griffith, Robert L. Dow, Aaron Smith 2014-10-14
8802690 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors David A. Griffith, Daniel Wei-Shung Kung 2014-08-12
8507681 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors David A. Griffith, Daniel Wei-Shung Kung 2013-08-13
8288405 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors David A. Griffith, Daniel Wei-Shung Kung 2012-10-16
7199243 Piperidine compounds useful as PPAR activators Thomas Brandt, Robert W. Dugger, William Hada, Cheryl M. Hayward, Zhengyu Liu 2007-04-03
5767310 Phenoxyphenylacetic acid derivatives Theodore P. Broten, Prasun K. Chakravarty, Daljit S. Dhanoa, Kenneth J. Fitch, William J. Greenlee +6 more 1998-06-16
5668176 Phenoxyphenylacetic acid derivatives Theodore P. Broten, Prasun K. Chakravarty, Daljit S. Dhanoa, Kenneth J. Fitch, William J. Greenlee +9 more 1997-09-16
5565485 Biphenyl compounds useful or endothelin antagonists Theodore P. Broten, Prasun K. Chakravarty, Daljit S. Dhanoa, Kenneth J. Fitch, William J. Greenlee +7 more 1996-10-15
5401745 Quinazolinones substituted with phenoxyphenylacetic acid derivatives Prasun K. Chakravarty, Anna Chen, Daljit S. Dhanoa, Kenneth J. Fitch, William J. Greenlee +4 more 1995-03-28